Medical Journals

Inhibition of Calpain and Caspase-3 Prevented Apoptosis and Preserved Electrophysiological Properties of Voltage-gated and Ligand-gated Ion Channels in Rat Primary Cortical Neurons Exposed to Glutamate.

Authors:
  • Ray S K
  • Karmakar S
  • Nowak M W
  • Banik N L

From: Department of Neurosciences, Medical University of South Carolina, 96 Jonathan Lucas Street, P.O. Box 250606, Charleston, SC 29425, USA. raysk@musc.edu

Neuroscience

  • Publish Date: May 2006
  • ISSN: 0306-4522
  • Volume: 139
  • Issue: 2
  • Pages: 577-95
  • Medium: Print
  • Language: English
  • Citation (JAMA): Ray S K, Karmakar S, Nowak M W, et al. Inhibition of Calpain and Caspase-3 Prevented Apoptosis and Preserved Electrophysiological Properties of Voltage-gated and Ligand-gated Ion Channels in Rat Primary Cortical Neurons Exposed to Glutamate.. Neuroscience May 2006;139:577-95

Abstract

Glutamate toxicity in traumatic brain injury, ischemia, and Huntington’s disease causes cortical neuron death and dysfunction. We tested the efficacy of calpain and caspase-3 inhibitors alone and in combination to prevent neuronal death and preserve electrophysiological functions in rat primary cortical neurons following glutamate exposure. Cortical neurons exposed to 0.5 microM glutamate for 24 h committed mostly apoptotic death as determined by Wright staining and ApopTag assay. Levels of expression, formation of active forms, and activities of calpain and caspase-3 were increased following glutamate exposure. Also, in situ double labeling identified conformationally active caspase-3-p20 fragment and chromatin condensation in apoptotic neurons. Pretreatment of cortical neurons with 0.2 microM N-benzyloxylcarbonyl-Leu-Nle-aldehyde (calpain-specific inhibitor) and 100 microM N-benzyloxylcarbonyl-Asp(OCH3)-Glu(OCH3)-Val-Asp(OCH3)-fluoromethyl ketone (caspase-3-specific inhibitor) provided strong neuroprotection. Standard patch-clamp techniques were used to measure the whole-cell currents associated with Na+ channels, N-methyl-D-aspartate receptors, and kainate receptors. The lack of a change in capacitance indicated that neurons treated with inhibitor(s) plus glutamate did not undergo apoptotic shrinkage and maintained the same size as the control neurons. Whole-cell currents associated with Na+ channels, N-methyl-D-aspartate receptors, and kainate receptors were similar in amplitude and activation/inactivation kinetics for cells untreated and treated with inhibitor(s) and glutamate. Spontaneous synaptic activity as observed by miniature end-plate currents was also similar. Prevention of glutamate-induced apoptosis by calpain and caspase-3 inhibitors preserved normal activities of crucial ion channels such as Na+ channels, N-methyl-D-aspartate receptors, and kainate receptors in neurons. Our studies strongly imply that calpain and caspase-3 inhibitors may also provide functional neuroprotection in the animal models of traumatic brain injury and neurodegenerative diseases.

Mesh Headings (Keywords): Amino Acid Chloromethyl Ketones, Animals, Animals, Newborn, Apoptosis, Calpain, Caspase 3, Caspases, Cell Survival, Cells, Cultured, Cerebral Cortex, Chromatin, Cysteine Proteinase Inhibitors, DNA Fragmentation, Drug Interactions, Female, Glutamic Acid, Ion Channel Gating, Membrane Potentials, Neurons, Oligopeptides, Pregnancy, Rats, Rats, Sprague-Dawley


Check for Full Text / PubMed Unique Identifier (PMID): 16504408


This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.

Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.

The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.


Advertisements

About | Privacy Policy | Business Solutions | Advertise | Contact | Add Healia to your site

©2012. Healia / Meredith Corporation  

Use of this site constitutes acceptance of our Terms of Service and Privacy Policy. All content on this Web site, including medical opinion and any other health-related information, is for informational purposes only and should not be used for a specific diagnosis or individual treatment plan for any situation. Use of this site and the information contained herein does not create a doctor-patient relationship. Always seek the direct advice of your doctor in connection with any questions or issues you may have regarding your own health or the health of others.